Official UK procurement notice
NHS National Generic Pharmaceuticals - Wave 15c
Authority: NHS England (Central government)
What is being bought3 lots · detail below
Published requirement descriptionNHS National Framework for Generic Pharmaceuticals - Wave 15c
Offer reference number: CM/PHG/23/5699
Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/01 Oral (plus non-parenteral) products
CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)
CM/PHG/23/5699/02 Hospital only products
DLS: 01/06/2026 to 31/05/2028 (24 months)
DNE: 01/06/2026 to 31/05/2028 (24 months)
CM/PHG/23/5699/03 Hospital only (housekeeping) products
DLN/DNW 01/06/2026 to 31/01/2027 (8 months)
DCE/DSW 01/06/2026 to 30/09/2027 (16 months)
CPV: Pharmaceutical products
How this framework works
From the published notice- Type
- Open framework
- Call-offs
- every call-off is a further competition among the appointed suppliers
- Bids received
- 117 bids on the busiest of 3 lots · 105 suppliers appointed
- Framework period
- 1 yr · up to 2 yrs from 1 Jun 2026
- Buyer regions
- UKC, UKD, UKE, UKF, UKG, UKH, UKI, UKJ, UKK
Who may buy through it
See Purchasing Points list in tender document set.
Published description of the framework
Please refer to the ITO Documents for the Operation Description.
Lots and requirements (3)Procurement structure
3 lots · all with a published valueLot #1CM/PHG/23/5699/01 Oral (plus non-parenteral) productsAwardedRenewalPublished value£14,377,000
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/01 Oral (plus non-parenteral) products:
CESW/LSNE/NWLN 01/06/2026 to 31/05/2027 (12 months)
Lot #2CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only productsAwardedRenewalPublished value£523,234,000
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products:
DLS: 01/06/2026 to 31/05/2028 (24 months)
DNE: 01/06/2026 to 31/05/2028 (24 months)
Lot #3CM/PHG/23/5699/03 Hospital only (housekeeping) productsAwardedRenewalPublished value£19,960,000
Potential periods of call-offs under the framework agreement:
CM/PHG/23/5699/03 Hospital only (housekeeping) products:
DLN/DNW 01/06/2026 to 31/01/2027 (8 months)
DCE/DSW 01/06/2026 to 30/09/2027 (16 months)
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS National Generic Pharmaceuticals - Wave 15c” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- See Purchasing Points list in tender document set.
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 20 May 2025, 15:48 BST
- Last source update
- 26 Feb 2026, 11:26 GMT
- Award evaluation window
- Submission end – 13 Jan 2026
- Authority reference
C382266- FTS notice number
2025/S 000-053094- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05193aFind a Tender
How it was run
Official notice- Appointment period ends
- 10 Oct 2025, 13:00 BST
- Clarification deadline
- 3 Oct 2025, 13:00 BST
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗
Additional information may be obtained from the abovementioned address.
Tenders must be submitted to the abovementioned address.
Timeline
20 May 2025 → 1 Jun 2026 · 11 dates- Planning notice published20 May 2025, 15:48 BST
- Market engagement29 Aug 2025, 23:59 BST
NHS England is advising suppliers of an upcoming tender for the NHS National Framework Agreement for the supply of Generic Pharmaceuticals, Wave 15c to commence on 1st June 2026 for varying dates of up to 24 months with the option to extend for a further 24 months.
This procurement will largely consist of hospital only products in the London South and North East regions, and will also include hospital only products in the remaining regions and oral products (plus non-parenterals) in all regions.
The purpose of this notice is to inform existing and potential new suppliers of this procurement.
Useful information for suppliers can be found here: www.england.nhs.uk/medicines-2/medicine… ↗ and the current generics workplan here: www.england.nhs.uk/publication/generics… ↗ .
Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.
- Tender notice published2 Sept 2025, 11:48 BST
- Next notice expected2 Sept 2025, 23:59 BST
- Clarification questions by383 days ago3 Oct 2025, 13:00 BST
- Admission / appointment period ends376 days ago · period end, not a bid countdown10 Oct 2025, 13:00 BST
- Assessment summaries sent282 days ago13 Jan 2026
- Award decision expected by281 days ago13 Jan 2026, 23:59 GMT
- Standstill ends271 days ago23 Jan 2026, 23:59 GMT
- Latest notice published237 days ago26 Feb 2026, 11:26 GMT
- Contract starts143 days ago1 Jun 2026, 00:00 BST
Notice history
15 events · 8 releases on Find a Tender · since 20 May 2025- Pipeline notice published20 May 2025, 15:48 BSTUK1
- Preliminary market engagement notice published14 Aug 2025, 15:27 BSTUK2
- Published value updated to £557,571,00014 Aug 2025, 15:27 BSTwas £260,000,000
- Tender notice published2 Sept 2025, 11:48 BSTUK4
- Status changed to active2 Sept 2025, 11:48 BST
- Procurement method changed2 Sept 2025, 11:48 BST
- Deadline published: 2 Oct 2025, 13:00 BST2 Sept 2025, 11:48 BST
- Tender notice published4 Sept 2025, 16:19 BSTUK4
- Tender notice published10 Sept 2025, 14:00 BSTUK4
- Deadline moved to 10 Oct 2025, 13:00 BST10 Sept 2025, 14:00 BST+8 days · was 2 Oct 2025, 13:00 BST
- Tender notice published10 Sept 2025, 14:19 BSTUK4
- Contract award notice published14 Jan 2026, 09:18 GMTUK6
- Status changed to complete14 Jan 2026, 09:18 GMT
- Contract signature expected27 Jan 2026, 23:59 GMTscheduled
- Contract details notice published26 Feb 2026, 11:26 GMTUK7
Published amendments (2)
Documents No 05a (iii) and 05a (iv) have been amended, please ensure most recent files are used to respond to this tender. Please disregard the original documents issued on the 2nd September 2025.
The following files have been replaced in the ITO procurement documents for Wave 15c: Document No. 01 - Invitation to offer covering letter V2 Document No. 02 - Terms of offer V2 Document No. 05a (iii) Product Listing and Usage - Hospital Only Products (DLS & DNE) CM-PHG-23-5699-02 V3 Document No. 05a (iv) Selectt Offer Schedule - Hospital Only Products (DLS & DNE) DM-PHG-5699-02 V3 The changes to…
Routine re-releases (8)
- 2025-09: 3 releases · 2 Sept 2025, 10 Sept 2025
- 2025-08: 1 release · 14 Aug 2025
- 2025-05: 1 release · 20 May 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Lot 1 · CM/PHG/23/5699/01 Oral (plus non-parenteral) products1 award | |||
| Amarox Pharma, Brown and Burk UK Ltd, Cipla EU Limited, Farmak PharmaceuticalsSME, Morningside Pharmaceuticals Limited, Novumgen Limited +10 more1 Jun 2026 – 31 May 2027 · up to 31 May 2028Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 24 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 24 months. | £17,727,000 | 13 Jan 2026 | Awarded |
| Lot 2 · CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products1 award | |||
| Aguettant Ltd, Aspire Pharma Ltd, Biocon Pharma UK Ltd, Chiesi Limited, Eramol (UK) LtdSME, Essential Pharma +98 more1 Jun 2026 – 31 May 2028 · up to 31 May 2030Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. | £403,702,000 | 13 Jan 2026 | Awarded |
| Lot 3 · CM/PHG/23/5699/03 Hospital only (housekeeping) products1 award | |||
| ACCORD-UK LTD, Aspire Pharma Ltd, Biocon Pharma UK Ltd, Bowmed Ibisqus Limited, Farmak PharmaceuticalsSME, Grindeks Kalceks UK Ltd +24 more1 Jun 2026 – 30 Sept 2027 · up to 31 Jan 2029Extensions: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 32 months. · Options: Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 32 months. | £37,160,000 | 13 Jan 2026 | Awarded |
Contracts
Lot 1 - CM/PHG/23/5699/01 Oral (plus non-parenteral) products · Amarox Pharma, Brown and Burk UK Ltd, Cipla EU Limited, Farmak PharmaceuticalsSME, Morningside Pharmaceuticals Limited, Novumgen Limited +10 more
- Signed
- 28 Jan 2026
- Value
- £17,727,000
- Period
- 1 Jun 2026 – 31 May 2027 · up to 31 May 2028 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 24 months.
Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products · Aguettant Ltd, Aspire Pharma Ltd, Biocon Pharma UK Ltd, Chiesi Limited, Eramol (UK) LtdSME, Essential Pharma +98 more
- Signed
- 28 Jan 2026
- Value
- £403,702,000
- Period
- 1 Jun 2026 – 31 May 2028 · up to 31 May 2030 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months.
Lot 3 - CM/PHG/23/5699/03 Hospital only (housekeeping) products · ACCORD-UK LTD, Aspire Pharma Ltd, Biocon Pharma UK Ltd, Bowmed Ibisqus Limited, Farmak PharmaceuticalsSME, Grindeks Kalceks UK Ltd +24 more
- Signed
- 28 Jan 2026
- Value
- £37,160,000
- Period
- 1 Jun 2026 – 30 Sept 2027 · up to 31 Jan 2029 with extensions
- Status
- active
- Extensions
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 32 months.
- Options
- Option or options to extend (at the authority’s discretion) for a period or periods up to a total of 32 months.
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · CM/PHG/23/5699/01 Oral (plus non-parenteral) products | 16final-stage tenders · 28 at stage one | 12 | 0 | — |
| 2 · CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only products | 117final-stage tenders | 78 | 0 | — |
| 3 · CM/PHG/23/5699/03 Hospital only (housekeeping) products | 34final-stage tenders · 52 at stage one | 21 | 0 | — |
Who bid (first 60 of 118)
- did not winCelix Pharma Ltd · Greater London · 2, 1
- wonMartindale Pharma · Greater London · 2, 3
- did not winmedac Pharma LLP · Greater London · 2
- did not winMerck Sharpe & Dohme (UK) Limited · Greater London · 2
- did not winMercury Pharmaceuticals · Greater London · 2, 3
- did not winMilpharm Ltd · Greater London · 2, 3
- wonMorningside Pharmaceuticals · East Midlands · 2, 1
- did not winMSN Laboratories Europe LimitedSME · East of England · 2
- did not winVIATRIS UK HEALTHCARE LIMITED · East of England · 2, 1
- did not winNecessity Supplies LimitedSME · Greater London · 2
- did not winNeon Healthcare Ltd · East of England · 2
- did not winNeuraxpharm UK Ltd · Wales (Cymru) · 2, 3
- did not winNorthumbria Pharma LimitedSME · North East England · 2, 3
- wonNovumgen Limited · Greater London · 2, 1
- did not winOrifarm UK Ltd · East of England · 2
- did not winOtsuka Pharmaceuticals UK LimitedSME · South East England · 2
- did not winPanpharma UK Limited · North West England · 2
- did not winPari Medical LimitedSME · Greater London · 2
- did not winPerennial Pharma Ltd · East of England · 2
- did not winPfizer Ltd · South East England · 2, 3
- did not winPhoenix Lab · 2
- did not winPiramal Critical care Limited · Greater London · 2
- did not winReig Jofre UK limited · South West England · 2
- did not winRoche Products Ltd · East of England · 2, 1
- did not winRoma Pharmaceuticals LimitedSME · West Midlands · 2
- did not winROVI Biotech LtdSME · Greater London · 2
- did not winRPH Pharmaceuticals AB · North West England · 2, 1
- did not winSandoz Ltd · South East England · 2, 3
- did not winSeacross Pharmaceuticals Ltd · East of England · 2, 3
- did not winSelective Supplies Ltd · Greater London · 2, 1
- did not winStirling Anglian Pharmaceuticals LtdSME · Scotland · 2
- did not winStrides Pharma UK LtdSME · East of England · 2
- did not winSun Pharma UK Ltd · Greater London · 2, 3
- did not winSVP Pharma LtdSME · East of England · 2
- did not winSynchrony · Greater London · 2
- did not winTakeda UK Ltd · Greater London · 2, 3
- did not winTeva UK Limited · Yorkshire and the Humber · all lots
- did not winThea Pharmaceuticals Limited · West Midlands · 2
- did not winThornton and Ross Ltd · Yorkshire and the Humber · 2
- did not winTillomed Laboratories ltd · East of England · 2
- did not winTorbay Pharmaceuticals · South West England · 2
- did not winTorrent Pharma UK Ltd · South East England · 2, 3
- did not winVantage Pharmaceuticals LtdSME · East of England · 2
- did not winWaymade PLC · East of England · 2
- did not winWockhardt UK Limited · Wales (Cymru) · 2, 3
- did not winZentiva Pharma UK Ltd · Greater London · 2, 3
- wonZydus Pharmaceuticals UK Ltd · South West England · 2, 1
- did not winAFT Pharma UKSME · Greater London · 2
- did not winArcadia Pharma Ltd T/A Arcadia MedicalSME · Wales (Cymru) · 2
- did not winAGB PharmaSME · 2
- did not winFlynn Pharma Ltd · 2
- wonAccord UK Ltd · South West England · 2, 3
- wonAguettant Ltd · South West England · 2
- did not winAlturix LimitedSME · Greater London · 2
- wonAmarox Limited · Greater London · all lots
- did not winAOP Orphan Ltd · South East England · 2
- did not winAscend Laboratories UK LtdSME · Greater London · 2
- did not winAscot Laboratories Ltd · East of England · 2
- did not winAspen Pharmacare UK Limited · Greater London · 2
- wonAspire Pharma Limited · South East England · 2, 3
Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.
Contracting authority & participating public bodies
Framework contractors & participating bidders
118 commercial parties on the notice · 45 awardedThe first 50 of 118 commercial parties (by name); the JSON mirror lists them all.
- AFT Pharma UKFramework contractor
- AGB PharmaFramework contractor
- AOP Orphan LtdFramework contractor
- Accord UK LtdFramework contractor
- Aguettant LtdFramework contractor
- Alturix LimitedFramework contractor
- Amarox LimitedFramework contractor
- Arcadia Pharma Ltd T/A Arcadia MedicalFramework contractor
- Ascend Laboratories UK LtdFramework contractor
- Ascot Laboratories LtdFramework contractor
Show 40 more suppliers
- Aspen Pharmacare UK LimitedFramework contractor
- Aspire Pharma LimitedFramework contractor
- Aventis Pharma ltd t/a SanofiFramework contractor
- B Braun Medical LimitedFramework contractor
- BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITEDBidder / tenderer
- Baxter Healthcare LtdFramework contractor
- Beaumont Pharma LtdFramework contractor
- BioconFramework contractor
- Bowmed Ibisqus LimitedFramework contractor
- Brown & Burk UK LtdFramework contractor
- CST Pharma LimitedFramework contractor
- Celix Pharma LtdFramework contractor
- Chiesi LimitedFramework contractor
- CiplaFramework contractor
- Colonis Pharma LtdFramework contractor
- Consilient Health LtdFramework contractor
- Crescent Pharma LtdFramework contractor
- Day Lewis Medical LtdFramework contractor
- Desitin Pharma LtdFramework contractor
- Dr.Reddy's Laboratories (UK) LimitedFramework contractor
- Drugsrus LtdFramework contractor
- EVER Pharma UK LtdBidder / tenderer
- EVOLAN PHARMA ABBidder / tenderer
- Eisai LimitedBidder / tenderer
- Eli Lilly & Co LimitedBidder / tenderer
- Ennogen Healthcare LtdFramework contractor
- Eramol (UK) LtdFramework contractor
- Essential PharmaFramework contractor
- Esteve Pharmaceuticals LtdFramework contractor
- Farmak PharmaceuticalsFramework contractor
- Flexipharm Austrading LimitedFramework contractor
- Flynn Pharma LtdFramework contractor
- Fontus Health LtdFramework contractor
- Fresenius Kabi LimitedFramework contractor
- G.L. Pharma UK LimitedFramework contractor
- Galen LimitedFramework contractor
- Galvany Pharma LtdFramework contractor
- Gennisium PharmaFramework contractor
- GlaxoSmithKline UK LimitedFramework contractor
- Glenmark Pharmaceuticals Europe LimitedFramework contractor
Official documents & specifications (50)
Official links; attachments are not copiedTender pack and attachments
- Bidding documents and specifications Document No. 05b - Selectt offer schedule instructions
- Bidding documents and specifications Document No. 06 - Form of offer
- Bidding documents and specifications Document No. 07 - Quality control technical sheet
- Bidding documents and specifications Document No. 08 - Confidential information schedule
- Bidding documents and specifications Document No. 09 - Pharmacy Purchasing Points List
- Bidding documents and specifications Document No. 10 - FOR INFO ONLY NOT FOR COMPLETION - PSQ Pass_Fail Criteria
- Bidding documents and specifications
- Bidding documents and specifications
Show 9 more documents
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
- Bidding documents and specifications
Notices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Tender notice Tender notice on Find a Tender
Show 4 more notices
- Tender notice Tender notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender
- Pipeline notice Pipeline notice on Find a Tender
21 further documents are listed in the JSON mirror.